The impact of coronary sinus narrowing on diastolic function in patients with refractory angina.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 08 12 2018
revised: 10 03 2019
accepted: 19 03 2019
pubmed: 14 4 2019
medline: 15 5 2020
entrez: 14 4 2019
Statut: ppublish

Résumé

Evaluating the impact of Coronary sinus (CS) narrowing on diastolic function. Narrowing of the CS is an emerging therapy for refractory angina pectoris, improving perfusion to the ischemic subendocardium and relieving ischemia and angina. It was speculated that increased CS pressure might cause interstitial myocardial edema and diastolic dysfunction. Prospective assessment of diastolic function was performed at baseline and 6 months following CS Reducer implantation in consecutive patients treated for refractory angina. Diastolic function assessment included left atrial volume, early transmitral filling peak velocity (E wave), E wave deceleration time (DT), transmitral atrial wave velocity (A wave), and early diastolic velocity of the septal (e' septal) and lateral (e' lateral) aspects of the mitral annulus. Twenty-four patients with chronic refractory angina and proven myocardial ischemia (mean age 69.3 ± 10.9 years) were included in the analysis. A wave velocity, E/A ratio, E wave DT and left atrial volume did not significantly change 6 months following Reducer implantation (p > 0.1 for all comparisons). A non-significant decrease in E wave velocity (80.5 ± 22.3 cm/s vs. 75.7 ± 17.5 cm/s, p = 0.19) and non significant increase in e' septal and lateral (5.28 ± 1.54 cm/s vs. 5.30 ± 1.71 cm/s, p = 0.95 and 8.26 ± 1.85 cm/s vs. 8.46 ± 2.07 cm/s, p = 0.69, respectively) led to a non-significant decrease in E/e' average ratio (12.6 ± 5.7 vs. 11.4 ± 3.3, p = 0.24). Mean diastolic function class significantly decreased following Reducer implantation from 1.5 ± 0.66 to 1.17 ± 0.76 (p = 0.008). Coronary sinus narrowing in patients with myocardial ischemia and refractory angina does not adversely affect diastolic function and may actually improve it.

Sections du résumé

OBJECTIVE
Evaluating the impact of Coronary sinus (CS) narrowing on diastolic function.
BACKGROUND
Narrowing of the CS is an emerging therapy for refractory angina pectoris, improving perfusion to the ischemic subendocardium and relieving ischemia and angina. It was speculated that increased CS pressure might cause interstitial myocardial edema and diastolic dysfunction.
METHODS
Prospective assessment of diastolic function was performed at baseline and 6 months following CS Reducer implantation in consecutive patients treated for refractory angina. Diastolic function assessment included left atrial volume, early transmitral filling peak velocity (E wave), E wave deceleration time (DT), transmitral atrial wave velocity (A wave), and early diastolic velocity of the septal (e' septal) and lateral (e' lateral) aspects of the mitral annulus.
RESULTS
Twenty-four patients with chronic refractory angina and proven myocardial ischemia (mean age 69.3 ± 10.9 years) were included in the analysis. A wave velocity, E/A ratio, E wave DT and left atrial volume did not significantly change 6 months following Reducer implantation (p > 0.1 for all comparisons). A non-significant decrease in E wave velocity (80.5 ± 22.3 cm/s vs. 75.7 ± 17.5 cm/s, p = 0.19) and non significant increase in e' septal and lateral (5.28 ± 1.54 cm/s vs. 5.30 ± 1.71 cm/s, p = 0.95 and 8.26 ± 1.85 cm/s vs. 8.46 ± 2.07 cm/s, p = 0.69, respectively) led to a non-significant decrease in E/e' average ratio (12.6 ± 5.7 vs. 11.4 ± 3.3, p = 0.24). Mean diastolic function class significantly decreased following Reducer implantation from 1.5 ± 0.66 to 1.17 ± 0.76 (p = 0.008).
CONCLUSION
Coronary sinus narrowing in patients with myocardial ischemia and refractory angina does not adversely affect diastolic function and may actually improve it.

Identifiants

pubmed: 30979603
pii: S0167-5273(18)37111-0
doi: 10.1016/j.ijcard.2019.03.041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-12

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Yishay Szekely (Y)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel.

Yan Topilsky (Y)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel.

Samuel Bazan (S)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel.

Miri Revivo (M)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel.

Shmuel Banai (S)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel.

Maayan Konigstein (M)

Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: maayan.konigstein@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH